Mounjaro is FDA-approved as a treatment to help adults with type 2 diabetes manage their blood sugar levels
[173] A 2025 observational study reported a modest increased risk of a serious eye condition in people with diabetes taking glucagon-like peptide-1 (GLP-1) receptor agonists
Risk Factors That May Increase Hypoglycaemia Risk Whilst GLP-1 receptor agonists carry a low intrinsic risk of hypoglycaemia when used as monotherapy, certain circumstances and combinations can increase the likelihood of low blood sugar episodes
This level of reduction is associated with meaningful health benefits, including lower blood pressure and improved cholesterol levels
Practical Tips for Traveling With Ozempic One of the benefits of Ozempic is its once-weekly dosing schedule, which makes it easier for patients to incorporate the medication into their routine
For active B12 deficiency, most clinicians recommend weekly or biweekly shots for the first 4 to 6 weeks, then a maintenance shot every 1 to 3 months